HBV Vaccines

DTH Reliable Marker for Vaccine Responsiveness

Published in Vaccine Weekly, October 30th, 1995

The development of delayed type hypersensitivity skin reaction is a reliable marker for the acquisition of active cellular immune responsiveness to hepatitis B antigens in people given hepatitis B vaccination, according to an Italian study.

The study also found that intradermal high dose hepatitis B vaccination is useful in nonresponders to intramuscular vaccine.

This study was presented at the 1995 Annual Meeting of the Infectious Disease Society of America, held September 15-20 in New Orleans, Louisiana.

Researcher G. Ghirga et al. evaluated the efficacy of a single high dose intradermal hepatitis B vaccination in healthy...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-10-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry